Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

MS&D designs potent and selective dopamine D4 antagonist

April 21, 1997

New opioid analgesic from Glaxo Wellcome

April 21, 1997

Warner-Lambert describes new dopamine D4 antagonists

April 18, 1997

New MMP inhibitor disclosed by Agouron

April 18, 1997

Pfizer characterizes new antipsychotic agent

April 17, 1997

New cell adhesion inhibitor from Biogen

April 17, 1997

Telomerase detection for bladder/prostatic cancer highlighted at AUA meeting

April 17, 1997

Dual TxA2/LT receptor antagonist selected for development by Yamanouchi

April 17, 1997

New fibrinogen antagonist from DuPont Merck

April 17, 1997

DuPont Merck presents new thrombin inhibitor

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...